$EHC

Encompass Health prices private offering of additional 5.875% senior notes due 2034

Encompass Health Corp. (NYSE: EHC) priced a private offering of $100 million additional 5.875% senior notes due 2034 at 98.75% of principal, reopening its May 2026 issue. Interest begins Dec. 1, 2026. Proceeds plus cash will repay amounts under its senior secured revolving credit facility. Expected close Aug. 13, 2026.

Original reporting
Published Aug 10, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 9:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Encompass Health prices private offering of additional 5.875% senior notes due 2034 — source image
Decision brief

The 30-second read

$EHCNeutralMed
01

Why it matters

The company will use net proceeds plus cash to repay outstanding amounts under its senior secured revolving credit facility, which can improve liquidity and potentially reduce interest expense depending on the revolver rate versus the new notes yield.

02

Market read

A defined debt financing with stated pricing and use of proceeds is actionable for credit and equity positioning around Aug. 13 closing and any subsequent spread moves.

03

What to watch

Revolver repayment reduces near-term liquidity risk, but the release does not quantify net leverage impact or any refinancing schedule beyond this transaction.

Relevance 7/10Novelty 7/10Timing: expected close Aug. 13, 2026, with proceeds to repay revolver

Background

Encompass Health is reopening previously issued 5.875% senior notes due 2034 via a private 144A/Reg S offering.

Company-level read

Ticker impact

$EHCNeutralMedium confidence
Context

Encompass Health priced a private offering of $100M additional 5.875% senior notes due 2034 at 98.75% to fund revolver repayment.

Expected impact

Near-term equity reaction likely limited; bond investors may focus on the 98.75% price and revolver paydown, with modest spread tightening if demand is strong.

Evidence & confidence

This is a capital-structure financing disclosure with defined size, coupon, maturity, and use of proceeds, but no guidance, earnings, or covenant changes.

Market effects

Healthcare providers with similar capital structures may see read-through on financing access and cost of debt, but this is company-specific.

None indicated.

None indicated.

Counterpoint

The 98.75% issue price could signal investors demand a yield premium, which may cap any positive read-through to credit quality.

Key entities

  • Encompass Health Corp.

    Priced $100M additional 5.875% senior notes due 2034 at 98.75% and plans to repay revolver borrowings.

  • 5.875% senior notes due 2034

    Additional notes are a reopening of the May 2026 issue, same terms except issuance date and offering price.

  • Senior secured revolving credit facility

    Outstanding amounts are targeted for repayment using offering proceeds and cash on hand.

Related articles

$EHCMed

Encompass Health Q2 Earnings Call Highlights

Encompass Health (NYSE:EHC) discussed Q2 updates on an earnings call. It expects Medicare pricing impact of about 2.3% in Q4 and 2026 salary/wage growth of 3.5% to 4.0%. It cut the 2026 net provider-tax benefit to about $10M from ~$21M. The company opened new beds, raised its dividend to $0.21, repurchased shares, and issued $500M notes, with net leverage at 1.9x.

$EHCMed

Encompass Health (EHC) Is Up 12.7% After Raising 2026 Guidance And Completing Major Buyback Program – Has The Bull Case Changed?

Encompass Health (EHC) reported Q2 2026 net operating revenue of $1,597.4 million and net income of $153.9 million, with higher EPS year over year. The company raised full-year 2026 revenue guidance and completed a major share repurchase program, retiring nearly one-tenth of shares, and increased shareholder returns. The article also cites higher debt after 2034 notes.

$EHCMedAI 8/10

Encompass Health: Q2 Earnings Snapshot

Encompass Health Corp. (EHC) reported Q2 profit of $153.9 million, or $1.54 per share. Adjusted EPS was $1.55, above Zacks’ estimate of $1.48. Revenue was $1.6 billion, above the $1.57 billion forecast. The company guided full-year EPS to $6.02-$6.25 and revenue to $6.41-$6.49 billion.

$EHCMedAI 8/10

Encompass Health reports results for second quarter 2026

Encompass Health (NYSE: EHC) reported Q2 2026 results for the quarter ended June 30, 2026. The company said revenue rose 9.6% and Adjusted EBITDA increased 9.2%. It raised full-year guidance and increased its common stock repurchase authorization to $1 billion, after repurchasing $145.8 million year to date.

Encompass Health prices private offering of additional 5.875% senior notes due 2034 — alphai